Kara Cardinale serves as principal of Kasper Cardinale Consulting, LLC, an independent health policy consultancy that provides strategic advice and analysis to clients on regulatory and legislative actions impacting the health care industry. She also serves on the District Policy Group's Advisory Board.
Previously, Ms. Cardinale served as a senior Medicare program examiner at the White House Office of Management and Budget (OMB) during enactment of the Affordable Care Act of 2010 and implementation of the Medicare Modernization Act of 2003. She was the lead OMB analyst on Medicare Part D and other policies related to the biopharmaceutical industry, including Medicare Part B drugs, biosimilars, and Medicare Advantage. Early in her career, Ms. Cardinale was a reporter for The Pink Sheet a trade publication covering the biopharmaceutical industry where she focused primarily on Food and Drug Administration regulatory policy. A native of Knoxville, Tennessee, Ms. Cardinale earned her bachelor of arts in philosophy from Haverford College and a master's of public policy from the University of Texas at Austin.